Jul 29, 2026 08:57PM
Jul 13, 2026 08:35PM
Jul 13, 2026 08:35PM
Jul 9, 2026 08:30PM
Jun 30, 2026 08:38PM
Jun 24, 2026 08:59PM
Apr 28, 2026 08:53PM Mesoblast completes patient recruitment for phase 3 chronic back pain trial
Apr 28, 2026 08:53PM
Apr 14, 2026 08:11PM
Apr 14, 2026 08:10PM
Apr 10, 2026 04:09PM
Apr 8, 2026 09:07AM
Apr 7, 2026 11:35PM
Mar 17, 2026 07:19PM Mesoblast to Host R&D Day on April 8, 2026
Mar 11, 2026 07:21PM
Feb 26, 2026 07:42PM
Feb 11, 2026 06:27PM
Jan 28, 2026 06:54PM
Jan 26, 2026 06:45PM
Jan 18, 2026 07:01PM
Jan 8, 2026 06:46PM Ryoncil® Sales Increase 60% in December Quarter to US$35.1M
Jan 1, 2026 06:02PM
Jan 1, 2026 06:02PM
Dec 29, 2025 06:57PM
Dec 11, 2025 06:22PM
Dec 3, 2025 06:10PM
Nov 24, 2025 06:39PM
Nov 20, 2025 06:32PM Mesoblast and BMT CTN to Initiate Pivotal Trial of Ryoncil® as Part of First-Line Regimen in Adults with Severe Acute GVHD Refractory to Steroids
Nov 4, 2025 06:40PM
Oct 19, 2025 07:48PM
Oct 6, 2025 07:24PM
Oct 2, 2025 09:04PM
Sep 26, 2025 01:49AM
Sep 14, 2025 09:18PM
Sep 3, 2025 09:47PM Mesoblast Enters Into Option To Issue US$50 Million Convertible Notes
Aug 28, 2025 08:24PM
Jul 17, 2025 08:38PM
Jun 30, 2025 08:36PM
Jun 11, 2025 09:24PM
May 14, 2025 11:36PM
May 14, 2025 10:57PM
Apr 29, 2025 08:53PM Appendix 4c Quarterly Activity Report for Quarter Ended March 31, 2025
Apr 28, 2025 07:44PM
Apr 3, 2025 06:58PM
Apr 2, 2025 07:15PM
Mar 30, 2025 07:39PM
Mar 13, 2025 07:42PM
Mar 6, 2025 06:54PM
Feb 26, 2025 05:30PM Mesoblast Sets Ryoncil® Price Based on Economic Value of Treatment With Planned Product Availability This Quarter
Feb 25, 2025 06:13PM

328,249 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All